Clinical trial / 2015
Onion peel extract supplementation for 12 weeks significantly improved flow-mediated dilation and circulating endothelial progenitor cells in overweight and obese adults.
A randomized, double-blind, placebo-controlled trial investigated the effect of 12 weeks of onion peel extract (OPE; 100 mg quercetin/d, n=36) versus placebo (n=36) in healthy overweight and obese individuals. Compared with baseline, the OPE group experienced a significant increase in flow-mediated dilation (from 12.5 ± 5.2 to 15.2 ± 6.1; P = 0.002), while the placebo group saw no change. Additionally, EPC counts increased significantly in the OPE group (from 44.2 ± 25.6 to 52.3 ± 18.6; P = 0.005), and the rate of participants in the lowest FMD quartile dropped from 26% to 9%.
- Study type
- Randomized double-blind, placebo-controlled trial
- Who was studied
- 72 healthy overweight and obese participants
- What was measured
- Flow-mediated dilation (FMD) and circulating endothelial progenitor cells (EPCs)
THE PAPER
Effect of onion peel extract on endothelial function and endothelial progenitor cells in overweight and obese individuals.
Choi EY, Lee H, Woo JS, Jang HH, Hwang SJ, Kim HS, Kim WS, Kim YS, Choue R, Cha YJ, Yim JE, Kim W. Nutrition, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.